Renal insufficiency, hyperparathyroidism, neuroendocrine neoplasms (NENs), and non‐neuroendocrine carcinomas (lung, colon, breast, and prostate carcinomas) can all raise serum calcitonin levels, as can some medicines.2 This evidence concerns the gene CALCA and prostate carcinoma.